Imagin Medical Inc C.IME

Alternate Symbol(s): IMEXF

Imagin Medical Inc. is a urologic oncology company. It is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence. The device is a disposable, focal therapy, precision ablation system that will deliver bipolar, radio frequency energy through a distinctive coil electrode, or cage. It enables the surgeon to preset margins for precise tissue targeting. Its second product, the i/Blue Imaging System, will bring several key technological advancements that improve the utility of blue light imaging for visualizing bladder cancer. The i/Blue System delivers blue light imaging technology in a more versatile, practical, and accessible format and is designed to work with existing fiberoptic endoscopes on the market.

CSE:IME - Post by User

Imagin Medical Inc

Bullboard Posts

Comment by Uknowiton Nov 28, 2017 7:40pm

90 Views

Post# 27050328

RE:RE:question.

Haven’t you read the NRs? Read the last sentence in the following:

Vancouver, B.C. and Boston, MA, November 9, 2017 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced today that Optel, Inc., the company’s optical product-design firm, will begin the redesign of the i/Blue Imaging System prototype for manufacturability and commercialization. The redesign will be concurrent with the first in-human research study using the i/Blue prototype that is anticipated to begin shortly at the University of Rochester Medical Center.

They are using the prototype type for the study. Quit spreading misinformation. Is there anyone else here doing their DD? Cheers.

Wrecker83 wrote:

radar77 wrote: When is the commencement of the trial going to be officially announced as it hasn’t as of yet other than wild speculation on this board. So this may start in Spring??

Suppose to start in early second quarter thats if they actually get the prototype done in time, if everything goes well this product may generate revenue in late 2019. This is a quick pump and dump be back in the teens in no time